Feedback / Questions
fenretinide (RT-101) - ReVision Therapeutics
dactolisib (RTB101) - Novartis, PureTech
blisibimod (A-623) - Anthera
sirolimus - generics
http://www.globenewswire.com/news-release/2019/05/20/1827711/0/en/resTORbio-Presents-Additional-Phase-2b-Data-at-the-American-Thoracic-Society-International-Conference-for-RTB101-as-a-Potential-Immunotherapy-to-Reduce-the-Incidence-of-Respiratory.html
May 20, 2019
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next